The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Abbvie; Allergan; Biogen; Gilead Sciences; GlaxoSmithKline; Merck
Research Funding - Bristol-Myers Squibb (Inst)
Lenalidomide and low-dose dexamethasone (Ld) is equivalent to Ld plus autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM): Results of a randomized, phase III trial.
 
Susanna Miao
Employment - Incyte (I); Sanofi (I)
Stock and Other Ownership Interests - Incyte (I)
 
Jordan Mark Schecter
Employment - Janssen Research & Development
Honoraria - Celgene; Seagen
Speakers' Bureau - Celgene; Seagen
 
Kent A. Griffith
No Relationships to Disclose
 
Daniel Paul Normolle
No Relationships to Disclose
 
Markus Y Mapara
Consulting or Advisory Role - Bristol-Myers Squibb (I); Celgene (I); Janssen (I); Novartis
Speakers' Bureau - Axiom Biotechnologies (I)
Research Funding - Celgene (Inst)
 
Robert L Redner
No Relationships to Disclose
 
Nicolas Villanueva
No Relationships to Disclose